{
    "nctId": "NCT02634541",
    "officialTitle": "The Efficacy of Adalimumab and Conventional Antirheumatic Drugs in Alleviating Axial and Aortic Inflammation Detected in PET/CT in Patients With Axial Spondyloarthritis",
    "inclusionCriteria": "* Axial spondyloarthritis (ASAS criteria) and radiologic sacroiliitis as detected either by MRI or X-ray.\n* Must have minimum age of 18 Years\n* Must have maximum age of 75 Years",
    "exclusionCriteria": "* Psoriasis or psoriasis arthropathy\n* Inflammatory bowel disease\n* Unwillingness to participate in the study with additional imaging protocols\n* Expected life-span less than \\<1 year\n* Diabetes (to improve the PET imaging quality)\n* Probable noncompliance\n* Pregnancy\n* Age \\<18 years or \\>75 years\n* Contraindication for adalimumab\n* Methotrexate used within the previous 6 months\n* A biologic medicine used within the previous 6 months"
}